HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA commissioner

This article was originally published in The Rose Sheet

Executive Summary

Bush Administration short list candidate Lynn Drake, MD, a dermatology lecturer at Harvard Medical School, may prove to be front-runner due to scientific/regulatory background and lack of direct industry ties. Senate Health Committee Chair Edward Kennedy (D-Mass.) stresses opposition to candidates with strong links to industry due to potential conflict of interest in July 13 letter to Administration. Former chair of FDA's Dermatologic & Ophthalmic Drugs Advisory Committee, Drake has spoken publicly on sun protection and skin cancer, most notably in appearance with former HHS Secretary Donna Shalala
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS009447

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel